Product NDC: | 50991-583 |
Proprietary Name: | DECONEX |
Non Proprietary Name: | Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Active Ingredient(s): | 15; 390; 10 mg/1; mg/1; mg/1 & nbsp; Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50991-583 |
Labeler Name: | Poly Pharmaceuticals |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120208 |
Package NDC: | 50991-583-60 |
Package Description: | 60 CAPSULE in 1 BOTTLE (50991-583-60) |
NDC Code | 50991-583-60 |
Proprietary Name | DECONEX |
Package Description | 60 CAPSULE in 1 BOTTLE (50991-583-60) |
Product NDC | 50991-583 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120208 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Poly Pharmaceuticals |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 15; 390; 10 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |